Next-Generation GLP-1 Therapies Reshape Global Pharmaceutical Market
The GLP-1 market represents one of the fastest-growing segments in the global healthcare industry, driven by increasing disease prevalence and rising adoption of advanced metabolic therapies. The market includes a wide range of glucagon-like peptide-1 receptor agonists used primarily for diabetes and obesity management, with expanding applications in cardiovascular care. According to Polaris...
0 Commentaires 0 Parts 107 Vue 0 Aperçu